vs
AGIOS PHARMACEUTICALS, INC.（AGIO）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
AGIOS PHARMACEUTICALS, INC.的季度营收约是RIVERVIEW BANCORP INC的1.4倍（$20.0M vs $14.0M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -541.1%，领先550.9%），AGIOS PHARMACEUTICALS, INC.同比增速更快（86.1% vs 10.4%），RIVERVIEW BANCORP INC自由现金流更多（$-736.0K vs $-97.3M），过去两年AGIOS PHARMACEUTICALS, INC.的营收复合增速更高（56.1% vs 24.6%）
Agios Pharmaceuticals是一家美国上市制药企业，创立于2008年，专注于开发针对基因定义疾病的创新疗法，近期核心方向为溶血性贫血治疗药物，总部位于马萨诸塞州剑桥市，2013年7月完成首次公开募股。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
AGIO vs RVSB — 直观对比
营收规模更大
AGIO
是对方的1.4倍
$14.0M
营收增速更快
AGIO
高出75.7%
10.4%
净利率更高
RVSB
高出550.9%
-541.1%
自由现金流更多
RVSB
多$96.6M
$-97.3M
两年增速更快
AGIO
近两年复合增速
24.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $20.0M | $14.0M |
| 净利润 | $-108.0M | $1.4M |
| 毛利率 | 90.6% | — |
| 营业利润率 | -608.9% | 12.4% |
| 净利率 | -541.1% | 9.8% |
| 营收同比 | 86.1% | 10.4% |
| 净利润同比 | -11.9% | 11.8% |
| 每股收益（稀释后） | $-1.86 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGIORVSB
| Q4 25 | $20.0M | $14.0M | ||
| Q3 25 | $12.9M | $13.6M | ||
| Q2 25 | $12.5M | $13.3M | ||
| Q1 25 | $8.7M | $12.9M | ||
| Q4 24 | $10.7M | $12.7M | ||
| Q3 24 | $9.0M | $12.8M | ||
| Q2 24 | $8.6M | $12.2M | ||
| Q1 24 | $8.2M | $9.0M |
净利润AGIORVSB
| Q4 25 | $-108.0M | $1.4M | ||
| Q3 25 | $-103.4M | $1.1M | ||
| Q2 25 | $-112.0M | $1.2M | ||
| Q1 25 | $-89.3M | $1.1M | ||
| Q4 24 | $-96.5M | $1.2M | ||
| Q3 24 | $947.9M | $1.6M | ||
| Q2 24 | $-96.1M | $966.0K | ||
| Q1 24 | $-81.5M | $-3.0M |
毛利率AGIORVSB
| Q4 25 | 90.6% | — | ||
| Q3 25 | 87.0% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 87.6% | — | ||
| Q4 24 | 88.3% | — | ||
| Q3 24 | 91.3% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 92.3% | — |
营业利润率AGIORVSB
| Q4 25 | -608.9% | 12.4% | ||
| Q3 25 | -907.4% | 10.2% | ||
| Q2 25 | -1020.1% | 11.7% | ||
| Q1 25 | -1222.0% | 11.3% | ||
| Q4 24 | -1165.3% | 12.4% | ||
| Q3 24 | -1146.9% | 15.5% | ||
| Q2 24 | -1228.3% | 10.0% | ||
| Q1 24 | -1124.3% | -47.5% |
净利率AGIORVSB
| Q4 25 | -541.1% | 9.8% | ||
| Q3 25 | -803.1% | 8.1% | ||
| Q2 25 | -899.4% | 9.2% | ||
| Q1 25 | -1023.3% | 8.9% | ||
| Q4 24 | -899.6% | 9.7% | ||
| Q3 24 | 10574.7% | 12.2% | ||
| Q2 24 | -1115.7% | 7.9% | ||
| Q1 24 | -995.8% | -34.7% |
每股收益（稀释后）AGIORVSB
| Q4 25 | $-1.86 | $0.07 | ||
| Q3 25 | $-1.78 | $0.05 | ||
| Q2 25 | $-1.93 | $0.06 | ||
| Q1 25 | $-1.55 | $0.05 | ||
| Q4 24 | $-1.44 | $0.06 | ||
| Q3 24 | $16.22 | $0.07 | ||
| Q2 24 | $-1.69 | $0.05 | ||
| Q1 24 | $-1.45 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.1M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $164.2M |
| 总资产 | $1.3B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AGIORVSB
| Q4 25 | $89.1M | $28.6M | ||
| Q3 25 | $92.7M | $32.8M | ||
| Q2 25 | $80.9M | $34.2M | ||
| Q1 25 | $79.0M | $29.4M | ||
| Q4 24 | $76.2M | $25.3M | ||
| Q3 24 | $253.7M | $31.0M | ||
| Q2 24 | $84.5M | $27.8M | ||
| Q1 24 | $118.8M | $23.6M |
股东权益AGIORVSB
| Q4 25 | $1.2B | $164.2M | ||
| Q3 25 | $1.3B | $163.5M | ||
| Q2 25 | $1.4B | $162.0M | ||
| Q1 25 | $1.5B | $160.0M | ||
| Q4 24 | $1.5B | $158.3M | ||
| Q3 24 | $1.6B | $160.8M | ||
| Q2 24 | $660.5M | $155.9M | ||
| Q1 24 | $743.9M | $155.6M |
总资产AGIORVSB
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.4B | $1.5B | ||
| Q2 25 | $1.5B | $1.5B | ||
| Q1 25 | $1.6B | $1.5B | ||
| Q4 24 | $1.7B | $1.5B | ||
| Q3 24 | $1.8B | $1.5B | ||
| Q2 24 | $773.1M | $1.5B | ||
| Q1 24 | $849.7M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-96.2M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $-97.3M | $-736.0K |
| 自由现金流率自由现金流/营收 | -487.5% | -5.2% |
| 资本支出强度资本支出/营收 | 5.6% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | $-377.3M | $20.4M |
8季度趋势，按日历期对齐
经营现金流AGIORVSB
| Q4 25 | $-96.2M | $-506.0K | ||
| Q3 25 | $-88.2M | $16.8M | ||
| Q2 25 | $-77.1M | $-697.0K | ||
| Q1 25 | $-111.5M | $8.3M | ||
| Q4 24 | $-133.2M | $2.2M | ||
| Q3 24 | $-84.2M | $764.0K | ||
| Q2 24 | $-72.6M | $5.4M | ||
| Q1 24 | $-99.9M | $12.8M |
自由现金流AGIORVSB
| Q4 25 | $-97.3M | $-736.0K | ||
| Q3 25 | $-89.7M | $16.4M | ||
| Q2 25 | $-78.0M | $-773.0K | ||
| Q1 25 | $-112.3M | $5.6M | ||
| Q4 24 | $-134.1M | $1.9M | ||
| Q3 24 | $-84.6M | $-1.4M | ||
| Q2 24 | $-72.7M | $5.3M | ||
| Q1 24 | $-100.0M | $7.1M |
自由现金流率AGIORVSB
| Q4 25 | -487.5% | -5.2% | ||
| Q3 25 | -696.5% | 120.1% | ||
| Q2 25 | -626.2% | -5.8% | ||
| Q1 25 | -1286.4% | 43.1% | ||
| Q4 24 | -1250.1% | 15.0% | ||
| Q3 24 | -944.2% | -11.3% | ||
| Q2 24 | -844.4% | 43.7% | ||
| Q1 24 | -1221.2% | 79.0% |
资本支出强度AGIORVSB
| Q4 25 | 5.6% | 1.6% | ||
| Q3 25 | 12.1% | 2.9% | ||
| Q2 25 | 7.0% | 0.6% | ||
| Q1 25 | 8.8% | 21.0% | ||
| Q4 24 | 9.0% | 2.4% | ||
| Q3 24 | 4.7% | 17.3% | ||
| Q2 24 | 1.8% | 0.9% | ||
| Q1 24 | 1.7% | 62.0% |
现金转化率AGIORVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | -0.09× | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
